Methylphenidate denied access to the WHO List of Essential Medicines for the second time | BMJ Evidence-Based Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

EBM analysis

Mental health

Methylphenidate denied access to the WHO List of Essential Medicines for the second time

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	876	19	12
Mar 2022	1025	25	11
Apr 2022	292	22	6
May 2022	162	11	3
Jun 2022	174	12	3
Jul 2022	247	9	2
Aug 2022	222	11	6
Sep 2022	274	10	3
Oct 2022	150	17	7
Nov 2022	245	11	7
Dec 2022	114	7	1
Jan 2023	105	6	4
Feb 2023	115	9	2
Mar 2023	440	24	9
Apr 2023	701	29	21
May 2023	393	21	12
Jun 2023	248	8	7
Jul 2023	202	14	7
Aug 2023	169	13	7
Sep 2023	160	8	3
Oct 2023	275	9	5
Nov 2023	132	7	4
Dec 2023	120	3	3
Jan 2024	101	7	4
Feb 2024	94	2	1
Mar 2024	119	4	2
Total	7155	318	152